help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 20, 2006
Molecular Endocrinology, doi:10.1210/me.2005-0348
A more recent version of this article appeared on August 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
20/8/1742    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubbink, H. J.
Right arrow Articles by Trapman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubbink, H. J.
Right arrow Articles by Trapman, J.

Submitted on August 30, 2005
Accepted on April 12, 2006

Androgen Receptor Ligand-Binding Domain Interaction and Nuclear Receptor Specificity of FXXLF and LXXLL motifs as determined by L/F swapping

Hendrikus J. Dubbink*, Remko Hersmus, Ashley C.W. Pike, Michel Molier, Albert O. Brinkmann, Guido Jenster, and Jan Trapman

Departments of Pathology and Urology, Josephine Nefkens Institute, Erasmus MC, PO Box 1738, 3000 DR Rotterdam, The Netherlands, Department of Reproduction & Development, Erasmus MC, PO Box 1738, 3000 DR Rotterdam, The Netherlands and Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, United Kingdom

* To whom correspondence should be addressed. E-mail: h.dubbink{at}erasmusmc.nl.

The androgen receptor (AR) ligand-binding domain (LBD) binds FXXLF motifs, present in the AR N-terminal domain and AR-specific cofactors, and some LXXLL motifs of nuclear receptor coactivators. We demonstrated that in the context of the AR FXXLF motif many different amino acid residues at positions +2 and +3 are compatible with strong AR LBD interaction, although a preference for E at +2 and K or R at +3 was found. Pairwise systematic analysis of F/L swaps at +1 and +5 in FXXLF and LXXLL motifs showed: (1) F to L substitutions in natural FXXLF motifs abolished AR LBD interaction; (2) binding of interacting LXXLL motifs was unchanged or increased upon L to F substitutions; (3) certain non-interacting LXXLL motifs became strongly AR-interacting FXXLF motifs, (4) while other non-binders remained unaffected by L to F substitutions. All FXXLF motifs, but not the corresponding LXXLL motifs, displayed a strong preference for AR LBD. Progesterone receptor LBD interacted with some FXXLF motifs, albeit always less efficiently than corresponding LXXLL motifs. AR LBD interaction of most FXXLF and LXXLL peptides depended on classical charge clamp residue K720, whereas E897 was less important. Other charged residues lining the AR coactivator-binding groove, K717 and R726, modulated optimal peptide binding. Interestingly, these four charged residues affected binding of individual peptides independent of an F or L at +1 and +5 in swap experiments. In conclusion, F residues determine strong and selective peptide interactions with AR. Sequences flanking the core motif determine the specific mode of FXXLF and LXXLL interactions.


Key words: androgen receptor • progesterone receptor • FXXLF motif • LXXLL motif • ligand-binding domain

NURSA Molecule Pages Link:

Nuclear Receptors:   TRβ  |  VDR  |  RXRα  |  ERα  |  PR  |  AR
Coregulators:   ARA54  |  SRC-1  |  GRIP1  |  ARA70
Ligands:   Calcitriol  |  17β-Estradiol  |  Dihydrotestosterone  |  9-cis-Retinoic acid  |  Progesterone  |  Thyroid hormone






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society